These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease. Ramírez-Carvajal L; Diaz-San Segundo F; Ramirez-Medina E; Rodríguez LL; de Los Santos T J Virol; 2016 Oct; 90(19):8809-21. PubMed ID: 27466421 [TBL] [Abstract][Full Text] [Related]
3. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Moraes MP; Chinsangaram J; Brum MC; Grubman MJ Vaccine; 2003 Dec; 22(2):268-79. PubMed ID: 14615155 [TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus. Wu Q; Brum MC; Caron L; Koster M; Grubman MJ J Interferon Cytokine Res; 2003 Jul; 23(7):359-68. PubMed ID: 14511462 [TBL] [Abstract][Full Text] [Related]
5. Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus. Dias CC; Moraes MP; Segundo FD; de los Santos T; Grubman MJ J Interferon Cytokine Res; 2011 Feb; 31(2):227-36. PubMed ID: 20874428 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine. Fernandez-Sainz I; Medina GN; Ramirez-Medina E; Koster MJ; Grubman MJ; de Los Santos T Virology; 2017 Feb; 502():123-132. PubMed ID: 28039799 [TBL] [Abstract][Full Text] [Related]
7. Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication. Ramírez-Carvajal L; Díaz-San Segundo F; Hickman D; Long CR; Zhu J; Rodríguez LL; de los Santos T J Virol; 2014 Oct; 88(19):11140-53. PubMed ID: 25031341 [TBL] [Abstract][Full Text] [Related]
8. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. Moraes MP; de Los Santos T; Koster M; Turecek T; Wang H; Andreyev VG; Grubman MJ J Virol; 2007 Jul; 81(13):7124-35. PubMed ID: 17459931 [TBL] [Abstract][Full Text] [Related]
9. Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs. Kim SM; Park JH; Lee KN; Kim SK; You SH; Kim T; Tark D; Lee HS; Seo MG; Kim B J Virol; 2015 Aug; 89(16):8267-79. PubMed ID: 26041279 [TBL] [Abstract][Full Text] [Related]
10. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs. Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133 [TBL] [Abstract][Full Text] [Related]
11. Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression. Diaz-San Segundo F; Moraes MP; de Los Santos T; Dias CC; Grubman MJ J Virol; 2010 Feb; 84(4):2063-77. PubMed ID: 19955313 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle. Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo. Chen W; Liu M; Jiao Y; Yan W; Wei X; Chen J; Fei L; Liu Y; Zuo X; Yang F; Lu Y; Zheng Z J Virol; 2006 Apr; 80(7):3559-66. PubMed ID: 16537624 [TBL] [Abstract][Full Text] [Related]
14. Type III interferon protects swine against foot-and-mouth disease. Perez-Martin E; Diaz-San Segundo F; Weiss M; Sturza DF; Dias CC; Ramirez-Medina E; Grubman MJ; de los Santos T J Interferon Cytokine Res; 2014 Oct; 34(10):810-21. PubMed ID: 24786495 [TBL] [Abstract][Full Text] [Related]
15. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response. Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486 [TBL] [Abstract][Full Text] [Related]
16. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Moraes MP; Mayr GA; Mason PW; Grubman MJ Vaccine; 2002 Feb; 20(11-12):1631-9. PubMed ID: 11858872 [TBL] [Abstract][Full Text] [Related]
17. Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs. Mayr GA; O'Donnell V; Chinsangaram J; Mason PW; Grubman MJ Vaccine; 2001 Feb; 19(15-16):2152-62. PubMed ID: 11228388 [TBL] [Abstract][Full Text] [Related]
18. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine. Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707 [TBL] [Abstract][Full Text] [Related]
19. A recombinant adenovirus bicistronically expressing porcine interferon-α and interferon-γ enhances antiviral effects against foot-and-mouth disease virus. Kim SM; Kim SK; Park JH; Lee KN; Ko YJ; Lee HS; Seo MG; Shin YK; Kim B Antiviral Res; 2014 Apr; 104():52-8. PubMed ID: 24485895 [TBL] [Abstract][Full Text] [Related]
20. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine. Pena L; Moraes MP; Koster M; Burrage T; Pacheco JM; Segundo FD; Grubman MJ Vaccine; 2008 Oct; 26(45):5689-99. PubMed ID: 18762225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]